embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results
Embecta Corp. (EMBC)
Company Research
Source: GlobeNewswire
PARSIPPANY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal fourth quarter and full year 2024 financial results, and provide an operational update, including preliminary fiscal year 2025 financial guidance, at 8:00 a.m. Eastern Time (ET) on Thursday, November 26, 2024. Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company’s website at investors.embecta.com. A webcast replay of the call will be available beginning at 11:00 a.m. ET on Nov 21, 2024, via the embecta investor relations website and archived on the website for one year. About embecta embecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solu
Show less
Read more
Impact Snapshot
Event Time:
EMBC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EMBC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EMBC alerts
High impacting Embecta Corp. news events
Weekly update
A roundup of the hottest topics
EMBC
News
- embecta to Participate at the 43rd Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- Here Is Why Bargain Hunters Would Love Fast-paced Mover Embecta Corp. (EMBC) [Yahoo! Finance]Yahoo! Finance
- Morgan Stanley bullish on medtech in 2025, upgrades 5 stocks [Seeking Alpha]Seeking Alpha
- New Strong Buy Stocks for December 2nd [Yahoo! Finance]Yahoo! Finance
- Embecta Corp. (NASDAQ: EMBC) was upgraded by analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating. They now have a $20.00 price target on the stock, up previously from $13.00.MarketBeat
EMBC
Earnings
- 11/26/24 - Beat
EMBC
Sec Filings
- 12/19/24 - Form ARS
- 12/19/24 - Form DEFA14A
- 12/19/24 - Form DEF
- EMBC's page on the SEC website